The use of arteriovenous fistula for cancer chemotherapy administration in hemodialysis patients.

J Vasc AccessJun 10, 2026 (epub)

Pedro Silva, Noemy Neves, Henrique Freixieiro et al.

✦ AI-curated · Sources linked

Case in brief

Two chronic hemodialysis patients received intravenous chemotherapy through a pre-existing mature arteriovenous fistula (AVF) using a peripheral catheter on non-dialysis days. The procedure was performed by experienced dialysis nursing staff, and no complications such as infection or access dysfunction were reported. Both patients maintained stable dialysis adequacy and AVF blood flow during follow-up.

Diagnostic / clinical pearl

Administering chemotherapy via a mature arteriovenous fistula in hemodialysis patients is technically feasible and safe, potentially preserving central venous access.

Why it matters

This approach may help maintain long-term vascular access integrity and reduce the need for invasive procedures in hemodialysis patients requiring chemotherapy.

Source

Published in J Vasc Access. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.